Curosurf Intratracheal Suspension

Share this animation:

Neonatal respiratory distress syndrome (RDS) is caused by inadequate surfactant production within the underdeveloped lung, which may result in atelectesis. Curosurf (poractant alfa) is an intratracheal surfactant suspension indicated for the rescue treatment of premature infants suffering from RDS.

Share It:
Contact XVIVO


Cornerstone Therapeutics

I recently worked with XVIVO on a lengthy and complex video for a new sleep medication that incorporated many different elements: live action, medical animation, abstract/artistic animation, music, and voice over. The end result was excellent; I couldnt possibly have been more pleased with the results or the process.

VP, Associate Creative Director, Revolution Health
Share this animation: